Brief: Guard Therapeutics International Q3 Operating Loss Widens To SEK 34.5 Mln
Nov 5 (Reuters) - Guard Therapeutics International AB (publ)
GUARD.ST :
* Q3 OPERATING LOSS SEK 34.5 MILLION VERSUS LOSS SEK 12.8
MILLION
YEAR AGO
* Q3 PRE-TAX LOSS SEK 34.5 MILLION VERSUS LOSS SEK 12.8
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN7X1ncz
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover